Van Damme N - Search Results

1

Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: A comparative population-based study.

Peirelinck H, Schulpen M, Hoogendijk R, Van Damme A, Pieters R, Henau K, Van Damme N, Karim-Kos HE. Peirelinck H, et al. Among authors: van damme n, van damme a. Int J Cancer. 2024 Jul 15;155(2):226-239. doi: 10.1002/ijc.34918. Epub 2024 Mar 13. Int J Cancer. 2024. PMID: 38478912

2

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group. Gatta G, et al. Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Lancet Oncol. 2017. PMID: 28687376 Free article.

3

Survival of patients with unfavorable prognosis cutaneous melanoma with increased use of immunotherapy agents: a population-based study in Belgium.

Castanares-Zapatero D, Verleye L, Devos C, Thiry N, Silversmit G, Van Damme N, De Gendt C, Hulstaert F, Neyt M. Castanares-Zapatero D, et al. Among authors: van damme n. Int J Dermatol. 2024 Jul;63(7):947-955. doi: 10.1111/ijd.17046. Epub 2024 Jan 31. Int J Dermatol. 2024. PMID: 38297428

4

Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study.

Estupiñán-Romero F, Royo-Sierra S, González-Galindo J, Martínez-Lizaga N, Bogaert P, Schutte N, Van Eycken L, Van Damme N, Henau K, Lyons RA, Aldridge SJ, Faragalli A, Carle F, Gesuita R, Palmieri L, Misiņš J, Thiβen M, Bernal-Delgado E. Estupiñán-Romero F, et al. Among authors: van damme n. Eur J Public Health. 2024 Jul 1;34(Supplement_1):i50-i57. doi: 10.1093/eurpub/ckae038. Eur J Public Health. 2024. PMID: 38946448 Free PMC article.

5

Policy brief of the Belgian Europe's Beating Cancer Plan mirror group: children, adolescents and young adults with cancer.

Poirel HA, Schittecatte G, Van Aelst F; on behalf of the Thematic Working Group (TWG) ‘Children, Adolescents and Young Adults (CAYAs) with Cancer’. Poirel HA, et al. Arch Public Health. 2024 Aug 27;82(Suppl 1):140. doi: 10.1186/s13690-024-01366-6. Arch Public Health. 2024. PMID: 39192310 Free PMC article.

6

Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in Belgium.

Leroy R, Silversmit G, Bourgeois J, De Gendt C, Savoye I, Verbeeck J, Van Damme N, Stordeur S, Canon JL, Carly B, Cusumano PG, de Azambuja E, De Visschere P, Decloedt J, Desreux J, Duhoux FP, Taylor D, van Dam P, Vanhoutte I, Veldeman L, Wildiers H. Leroy R, et al. Among authors: van damme n. Eur J Cancer. 2024 Oct;210:114232. doi: 10.1016/j.ejca.2024.114232. Epub 2024 Jul 20. Eur J Cancer. 2024. PMID: 39236426

7

Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level study.

Peacock HM, van Walle L, Silversmit G, Neven P, Han SN, Van Damme N. Peacock HM, et al. Among authors: van damme n. Arch Public Health. 2024 May 7;82(1):66. doi: 10.1186/s13690-024-01296-3. Arch Public Health. 2024. PMID: 38715074 Free PMC article.

8

Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013-2019): a nationwide registry-based prospective study.

Lievens Y, Janssens S, Lambrecht M, Engels H, Geets X, Jansen N, Moretti L, Remouchamps V, Roosens S, Stellamans K, Verellen D, Weltens C, Weytjens R, Van Damme N; Belgian College for Physicians of Radiation Oncology Centres. Lievens Y, et al. Among authors: van damme n. Lancet Reg Health Eur. 2024 Jul 6;44:100992. doi: 10.1016/j.lanepe.2024.100992. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39045286 Free PMC article.

9

Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.

De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. De Angelis R, et al. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. Lancet Oncol. 2024. PMID: 38307102

10

Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.

Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group. Sant M, et al. Lancet Oncol. 2024 Jun;25(6):731-743. doi: 10.1016/S1470-2045(24)00141-4. Epub 2024 May 1. Lancet Oncol. 2024. PMID: 38703784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters